#AskDrDurie

Learn about the latest myeloma research. Get a front row seat at the most critical medical meetings. Watch Dr. Brian Durie, IMF Chairman, address issues that are important to the entire myeloma community. IMF TV brings it all to you.

Jan
17
When discussing improvements in the available treatments for multiple myeloma, do small steps really equal progress?
In this week’s video, Dr. Brian G.M. Durie discusses whether or not small steps in the available treatments for multiple myeloma can be considered progress.
Jan
10
What is the difference between genetic testing, such as FISH testing, and DNA testing?
In this week’s video, Dr. Brian Durie identifies key takeaways for myeloma patients from the ASH 2016 abstracts.
Dec
13
Does a multiple myeloma patient whose disease has relapsed, need to undergo a second autologous stem cell transplant?
In this week’s video, Dr. Brian G.M. Durie discusses other options to consider if your doctor recommends a second autologous stem cell transplant.
Dec
05
How do multiple myeloma experts define cure?
In this week’s video, Dr. Brian G.M. Durie explains the two definitions for cure in multiple myeloma – functional cure and true cure. BOTTOM LINE: ​ We are still unable to define cure, but the good(...)
Nov
29
Can adrenal insufficiency occur when dexamethasone treatment is abruptly stopped?
In this week’s video, Dr. Brian G.M. Durie recommends what to do if the use of dexamethasone or other steroids cause adrenal insufficiency.
Nov
15
What is the status of Empliciti® (elotuzumab), the new immunotherapy?
In this week’s video, Dr. Brian G.M. Durie explains the recent FDA approval for the use of elotuzumab, pomalidomide, and dexamethasone (EPd) for the treatment of relapsed or refractory myeloma in(...)